Best Weight Loss Injections Reviews UK | Cured Pharmacy

Clinically Proven UK Registered Pharmacy

Best Weight Loss Injections Reviews - Lowest Price UK

UK-registered clinical team
Confidential and secure
No GP visit needed
Fast and discreet delivery
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £10 off for new customers
Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment
£145.00 From £135.00 £10 discount using discount code Weightlossnew
LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro Weight Loss Injections (Tirzepatide) KwikPen - UK-licensed prescription Treatment
Treatment

Mounjaro Weight Loss Injections (Tirzepatide) KwikPen

From £145.00

Future orders save 5%
Start Assessment
Wegovy (Semaglutide) Weight Loss Injection - UK-licensed prescription Treatment
Treatment

Wegovy (Semaglutide) Weight Loss Injection

From £89.00

Future orders save 5%
Start Assessment
Saxenda - UK-licensed prescription Treatment
Treatment

Saxenda

From £68.00

Future orders save 5%
Start Assessment
Orlistat - UK-licensed prescription Treatment
Treatment

Orlistat

From £32.00

Future orders save 5%
Start Assessment
Xenical Orlistat 120mg Capsules - UK-licensed prescription Treatment
Treatment

Xenical Orlistat 120mg Capsules

From £49.99

Future orders save 5%
Start Assessment
Wegovy® Oral Tablets (Semaglutide Pill): PRE-ORDER - UK-licensed prescription Treatment
Treatment

Wegovy® Oral Tablets (Semaglutide Pill): PRE-ORDER

From £83.00

Future orders save 5%
Start Assessment

Best Weight Loss Injections Reviews - Lowest Price UK

Published on: June 03, 2026

Searching for the best weight loss injections reviews UK with transparent pricing? At Cured Pharmacy, we offer UK-licensed weight loss injections including Mounjaro, Wegovy, and Saxenda, all dispensed following a free clinical consultation with our UK-registered prescribers. Our patients benefit from guaranteed lowest prices, genuine medications, and completely discreet packaging delivered directly to your door.

How GLP-1 Weight Loss Injections Work

GLP-1 receptor agonists are a class of injectable medications that mimic naturally occurring hormones in your body to regulate appetite and blood sugar levels [1]. These medications work by slowing gastric emptying, reducing hunger signals to the brain, and improving insulin sensitivity, creating a multi-pathway approach to sustainable weight management.

Clinical trials have demonstrated that GLP-1 treatments can produce significantly greater weight loss compared to lifestyle interventions alone. In the STEP 1 trial, participants using semaglutide achieved an average 14.9% body weight reduction over 68 weeks, whilst the SURMOUNT-1 trial showed tirzepatide users lost up to 22.5% of their initial body weight [1][2]. These results represent some of the most substantial weight reductions ever recorded in pharmaceutical obesity treatment.

The MHRA has licensed several GLP-1 medications for weight management in the UK, each with distinct pharmacological profiles. Your response to treatment depends on multiple factors including your baseline BMI, metabolic health, adherence to prescribed dosing schedules, and concurrent lifestyle modifications. All prescription weight loss injections available through Cured Pharmacy require clinical assessment by a UK prescriber to ensure suitability and safety.

Mounjaro (Tirzepatide): Dual-Action Weight Loss Treatment

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed in the UK for chronic weight management [2]. Unlike single-pathway GLP-1 medications, tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptors, producing enhanced metabolic effects and superior weight loss outcomes in head-to-head clinical comparisons.

The SURPASS clinical trial programme demonstrated tirzepatide's exceptional efficacy across multiple dosing strengths. In SURPASS-2, participants on the 15mg maintenance dose achieved an average 12.4kg weight reduction compared to 6.2kg with semaglutide 1mg over 40 weeks [2]. The medication is administered once weekly via a pre-filled KwikPen injector, with dosing gradually titrated from 2.5mg to a maximum of 15mg based on individual tolerance and response.

At Cured Pharmacy, Mounjaro is available from £135.00, representing the lowest guaranteed price for genuine UK-licensed tirzepatide in the country. Your treatment begins with a free online consultation completed in under three minutes, reviewed by our UK-registered clinical team including superintendent pharmacist Tarun Kumar (GPhC 2233073). Subject to prescriber approval, your medication is dispensed from our GPhC-registered pharmacy (9012511) and delivered in completely discreet packaging.

Who Can Use Mounjaro?

Mounjaro is licensed for adults with a BMI of 30 kg/m² or greater, or 27 kg/m² with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or dyslipidaemia [2]. Your UK prescriber will assess your full medical history, current medications, and contraindications during the consultation process. Common exclusions include pregnancy, breastfeeding, personal or family history of medullary thyroid carcinoma, and multiple endocrine neoplasia syndrome type 2.

Wegovy (Semaglutide): Proven Weight Loss Results

Wegovy contains semaglutide, a GLP-1 receptor agonist extensively studied in the STEP clinical trial programme involving over 4,500 participants [1]. The medication works by mimicking the GLP-1 hormone to reduce appetite, slow gastric emptying, and improve glycaemic control, creating sustainable conditions for significant weight reduction when combined with dietary and exercise modifications.

In the landmark STEP 1 trial, participants receiving semaglutide 2.4mg weekly achieved an average 14.9% reduction in body weight over 68 weeks, compared to 2.4% with placebo [1]. Notably, 86% of semaglutide users achieved at least 5% weight loss, whilst 69% reached the clinically significant threshold of 10% or greater reduction. These results established semaglutide as one of the most effective pharmaceutical interventions for obesity management.

Wegovy is administered once weekly via a pre-filled FlexTouch pen, with dosing escalated gradually from 0.25mg to the maintenance dose of 2.4mg over 16 weeks. This titration schedule minimises gastrointestinal side effects whilst allowing your body to adapt to the medication's metabolic effects. Treatment requires ongoing clinical supervision, and your UK prescriber will monitor your progress and adjust dosing as clinically appropriate.

Wegovy Dosing Schedule

The standard Wegovy titration follows a structured 16-week escalation: 0.25mg weekly for 4 weeks, 0.5mg for 4 weeks, 1mg for 4 weeks, 1.7mg for 4 weeks, then maintenance at 2.4mg weekly [1]. This gradual increase significantly reduces the incidence of nausea and gastrointestinal discomfort reported in clinical trials. Your prescriber may adjust this schedule based on your individual tolerance and clinical response.

Treatment Active Ingredient Dosing Frequency Average Weight Loss Starting Price
Mounjaro Tirzepatide Once weekly Up to 22.5% (72 weeks) From £124.99
Wegovy Semaglutide 2.4mg Once weekly Average 14.9% (68 weeks) From £69.00
Saxenda Liraglutide 3mg Daily injection Average 8% (56 weeks) From £68.00
Orlistat 120mg Orlistat Three times daily (oral) Average 2.9kg vs placebo From £32.00

Comparing Weight Loss Injections: Clinical Evidence

Direct comparison trials provide valuable insights into relative efficacy between different GLP-1 medications. The SURPASS-2 head-to-head study compared tirzepatide against semaglutide 1mg in participants with type 2 diabetes, demonstrating superior weight loss with all tirzepatide doses [2]. At 40 weeks, the 15mg tirzepatide group achieved 12.4kg average reduction versus 6.2kg with semaglutide, representing nearly double the weight loss outcome.

However, medication selection involves more than efficacy data alone. Tolerability profiles differ between agents, with tirzepatide showing higher rates of gastrointestinal side effects in some trials but also greater discontinuation rates with semaglutide in others [1][2]. Individual patient factors including injection frequency preference, previous GLP-1 exposure, comorbid conditions, and cost considerations all influence the optimal choice.

Your UK prescriber at Cured Pharmacy will evaluate your complete medical profile, weight loss goals, and treatment preferences during your consultation. Both tirzepatide and semaglutide require commitment to concurrent lifestyle modifications for optimal results. Clinical guidelines emphasise that these medications are adjuncts to, not replacements for, reduced-calorie diets and increased physical activity [3].

Saxenda (Liraglutide): Daily Injection Alternative

Saxenda contains liraglutide, an earlier-generation GLP-1 receptor agonist administered via daily subcutaneous injection [4]. Whilst newer weekly formulations have largely superseded daily options, liraglutide remains a valuable alternative for patients who prefer more frequent dosing or have contraindications to longer-acting GLP-1 medications.

The SCALE clinical programme demonstrated liraglutide 3mg daily produced an average 8% body weight reduction over 56 weeks, with 63.2% of participants achieving at least 5% weight loss [4]. These outcomes, whilst more modest than those observed with tirzepatide or high-dose semaglutide, still represent clinically meaningful improvements in metabolic health markers including HbA1c, blood pressure, and lipid profiles.

Saxenda is titrated from 0.6mg daily up to the maintenance dose of 3mg over five weeks, allowing gradual adaptation to the medication's effects. The daily injection schedule requires greater treatment adherence compared to weekly alternatives, but some patients report better appetite control with the more frequent dosing pattern. Your prescriber will discuss whether daily or weekly administration better suits your lifestyle and treatment goals.

Saxenda vs Weekly Injections

The primary distinction between Saxenda and newer GLP-1 medications lies in administration frequency and magnitude of weight loss. Whilst Saxenda requires daily injections and typically produces 8-9% average weight reduction, weekly options like Wegovy and Mounjaro deliver 15-22% reductions with once-weekly dosing [1][2][4]. However, individual responses vary considerably, and some patients achieve excellent results with liraglutide whilst experiencing intolerable side effects with longer-acting formulations.

Oral Weight Loss Medications: Orlistat and Alternatives

For patients who prefer non-injectable options, oral weight loss medications provide an alternative approach to pharmaceutical weight management. Orlistat, available as prescription-strength 120mg (Xenical) or over-the-counter 60mg formulations (Alli, Orlos), works through a completely different mechanism than GLP-1 injections by inhibiting pancreatic lipase enzymes that digest dietary fats [5].

Clinical trials demonstrate orlistat 120mg three times daily produces an average 2.9kg greater weight loss compared to placebo over one year when combined with a reduced-calorie diet [5]. Whilst these results are more modest than injectable GLP-1 medications, orlistat offers advantages including oral administration, no injection-related side effects, and suitability for patients with contraindications to incretin-based therapies.

The primary tolerability consideration with orlistat involves gastrointestinal effects related to its mechanism of action. Undigested fats passing through the digestive system can cause oily stools, flatulence, and faecal urgency, particularly when consuming high-fat meals [5]. These effects are manageable through dietary fat restriction and typically diminish as patients adapt their eating patterns. Your prescriber will assess whether orlistat's risk-benefit profile suits your individual circumstances and weight loss objectives.

Scientific References

  1. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., Wharton, S., Yokote, K., Zeuthen, N., & Kushner, R. F. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
  2. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., Kiyosue, A., Zhang, S., Liu, B., Bunck, M. C., & Stefanski, A. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
  3. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (Clinical guideline CG189). NICE. https://www.nice.org.uk/guidance/cg189 [accessed 13 August 2026]
  4. Pi-Sunyer, X., Astrup, A., Fujioka, K., Greenway, F., Halpern, A., Krempf, M., Lau, D. C. W., le Roux, C. W., Violante Ortiz, R., Jensen, C. B., & Wilding, J. P. H. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
  5. Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155–161. https://doi.org/10.2337/diacare.27.1.155 [accessed 13 August 2026]
  6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
  7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
  8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to prescribed treatment, dietary modifications, and physical activity levels.

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

Which weight loss injection is most effective in the UK?
Clinical trial data shows tirzepatide (Mounjaro) produces the greatest average weight loss at up to 22.5% body weight reduction over 72 weeks, followed by semaglutide 2.4mg (Wegovy) at 14.9% over 68 weeks. However, individual responses vary, and your UK prescriber will recommend the most suitable option based on your medical history and treatment goals.
How much do weight loss injections cost in the UK?
At Cured Pharmacy, Mounjaro starts from £135.00, Wegovy from £135.00, and Saxenda from £135.00, representing the lowest guaranteed prices for genuine UK-licensed medications. Final costs depend on your prescribed dose and treatment duration, determined during your free clinical consultation with our UK-registered prescribers.
Do I need a prescription for weight loss injections in the UK?
Yes, all GLP-1 weight loss injections including Mounjaro, Wegovy, and Saxenda are prescription-only medications in the UK. You must complete a clinical assessment with a UK-registered prescriber who will evaluate your suitability, medical history, and contraindications before prescribing treatment.
What are the common side effects of GLP-1 weight loss injections?
The most frequently reported side effects are gastrointestinal, including nausea, diarrhoea, constipation, and abdominal discomfort, typically occurring during dose escalation phases. These effects usually diminish over 4-8 weeks as your body adapts. Serious but rare risks include pancreatitis, gallbladder disease, and thyroid tumours, which your prescriber will discuss during consultation.
How long does it take to see results from weight loss injections?
Most patients begin noticing appetite reduction within 1-2 weeks of starting treatment, with measurable weight loss typically evident by week 4. Maximum weight loss generally occurs between 60-72 weeks of continuous treatment, though individual timelines vary based on adherence, lifestyle modifications, and metabolic factors.
Can I use weight loss injections if I have type 2 diabetes?
Yes, both tirzepatide and semaglutide are licensed for use in patients with type 2 diabetes and can improve glycaemic control alongside promoting weight loss. However, dose adjustments to existing diabetes medications may be necessary to prevent hypoglycaemia. Your prescriber will coordinate treatment with your diabetes care team to ensure safe, effective management.
Are weight loss injections available on the NHS?
NHS availability of weight loss injections is limited and subject to strict eligibility criteria including specific BMI thresholds and participation in specialist weight management services. Waiting times can extend to several months or longer depending on local commissioning decisions. Private prescription through registered UK pharmacies like Cured Pharmacy offers immediate access subject to clinical suitability.
What happens when I stop taking weight loss injections?
Clinical trial extension studies show that discontinuing GLP-1 medications typically results in gradual weight regain, with participants regaining approximately two-thirds of lost weight within one year of stopping treatment. Maintaining weight loss requires ongoing lifestyle modifications including dietary changes and regular physical activity, with or without continued pharmacological support.
How much do weight loss injections cost at Cured Pharmacy?
Weight loss injection prices at Cured Pharmacy vary depending on the specific treatment and dosage strength you require. Our team provides transparent pricing during your free online consultation, with options to suit different budgets and treatment plans.
Do I need a prescription for weight loss injections in the UK?
Yes, weight loss injections are prescription-only medications in the UK and require medical approval. Cured Pharmacy offers a free online consultation with our UK-registered prescribers who will assess your suitability and issue a prescription if appropriate.
How quickly can weight loss injections be delivered in the UK?
Cured Pharmacy offers fast, discreet delivery across the UK, typically within 1-3 working days of prescription approval. All weight loss injections are dispatched in plain, unmarked packaging to protect your privacy and arrive directly to your chosen address.
What are the most reviewed weight loss injections in the UK?
The most commonly reviewed weight loss injections in the UK include Wegovy, Mounjaro, and Saxenda, all available through Cured Pharmacy. Our customers frequently share their experiences with these GLP-1 treatments, helping others make informed decisions about their weight management journey.
Are weight loss injections safe for long-term use?
Weight loss injections approved in the UK have been extensively studied for safety and efficacy over extended periods. Cured Pharmacy ensures ongoing monitoring through regular consultations with our medical team, who assess your progress and adjust treatment as needed to maintain safe, effective results.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 13 August 2026

Last updated on 13 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 13 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (13 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.